TPST financials
Tempest Therapeutics (TPST) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TPST income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$26.57M | -$26.26M | -6.33 |
| 2024 | – | – | -$42.03M | -$41.84M | -19.50 |
| 2023 | – | – | -$29.16M | -$29.49M | -24.83 |
| 2022 | – | – | -$34.64M | -$35.71M | -40.17 |
| 2021 | – | – | -$26.99M | -$28.30M | -97.11 |
| 2020 | – | – | -$19.30M | -$19.21M | -533.39 |